Johnson & Johnson MedTech has announced the U.S. launch of the VIRTUGUIDE™ System, following the 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pre-operative Planning Software. This AI-powered, patient-matched solution is designed to simplify the Lapidus procedure, a type of bunion surgery. Early reports indicate that the system can reduce surgical time by 30 minutes compared to traditional methods. The VIRTUGUIDE™ System, developed in collaboration with PeekMed®, is now available in the U.S., marking a significant advancement in surgical precision for bunion deformities.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.